131
Participants
Start Date
March 13, 2006
Primary Completion Date
January 23, 2007
Study Completion Date
January 23, 2007
Metvix-PDT
Metvix 160 mg/g Cream was applied for 3 hours with occlusive dressing, and illumination with non-coherent red light using the Aktilite CL128 lamp, with a total light dose 37 Joule/square centimeter (J/cm²). All eligible lesions on the participant were treated twice with an interval of 1 week between treatments.
Vehicle-PDT
Vehicle Cream was applied for 3 hours with occlusive dressing, and illumination with non-coherent red light using the Aktilite CL128 lamp, with a total light dose 37 J/cm². All eligible lesions on the participant were treated twice with an interval of 1 week between treatments.
Klinik für Dermatologie und Venerologie Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck
Joseph Fowler, Louisville
Hautklinik Heinrich Heine Universität, Düsseldorf
Ashish C. Bhatia, Naperville
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt
Steven A. Davis, San Antonio
Klinikum der Universität München, Klinikum und Poliklinik für Dermatologie und Allergologie, München
Praxis Dr. Winfried Klövekorn, Gilching
Praxis Dr. Klemm, Tutzing
Klinik und Poliklinik für Dermatologie, Klinikum der Universität Regensburg, Regensburg
Robert T. Matheson, Portland
Lead Sponsor
Galderma R&D
INDUSTRY